Miguel Martin

Aurora Reports 20% YoY Uptick In Global Medical Marijuana, Expects Benefits From International Cannabis Regulatory Reforms
Weed Legalization In Germany Just Took Effect: Here's What You Need To Know
Aurora Cannabis (ACB): Canaccord Genuity Analysts Say Now's The Time To Buy. Find Out Why
Weed Legalization In Germany Just Took Effect: Here's What You Need To Know
Aurora Cannabis (ACB): Canaccord Genuity Analysts Say Now's The Time To Buy. Find Out Why
EXCLUSIVE: Aurora Cannabis CEO Discusses Record Earnings And Strategic Global Expansion (VIDEO)
Aurora Touts 41% YoY Increase In International Medical Cannabis Q3 Revenue, Expands In Australia Via New Acquisition

Miguel Martin Recent News

Aurora Cannabis And Willow Biosciences Resolve Patent Clash
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced Tuesday that it had successfully completed a confidential settlement ‎resolving an ongoing patent litigation with Willow Biosciences Inc. (OTCQB:
Aurora And Curaleaf Cannabis Companies Each Close Multi-Million Dollar Funding Deals
Two cannabis giants each closed their respective funding deals on Tuesday.
Canadian Cannabis Giant Takes Strategic Steps To Reduce Debt & Boost Financial Stability
Aurora Cannabis Inc.
Aurora Cannabis Takes Bold Step Towards Financial Recovery
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has repurchased an aggregate of roughly CA$12.3 million ($9 million) principal amount of its convertible senior notes in multiple transactions between August 16 and September 8, 2023.
Aurora Cannabis Releases Strong Q1 2024 Financial Results Highlighting Substantial Adjusted EBITDA Growth
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) reported its financial results for Q1 fiscal year 2024, ending on June 30, 2023.
Aurora Cannabis Sells Sun Facility To Bevo
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) announced that a wholly-owned subsidiary of the company has closed the sale of its Medicine Hat, Alberta facility (the "Aurora Sun facility&
Weed Giant Aurora Posts Gross Profit Collapse: With The Drop From $16M To $583.3K, Does 3 Months Shorter Fiscal Year Matter?
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) released its financial and operational results for the third quarter and fiscal year 2023 results. The company’s fiscal 2023 is comprised of three quarters ending March 31, 2023.
Aurora And MedReleaf Australia Launch IndiMed Tempo 26, Expanding Product Offerings For Medical Cannabis Patients
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB),and MedReleaf Australia launched IndiMed Tempo 26, a range of new higher THC dried cannabis products for qualified patients under the MedReleaf Concession Scheme.
'Cannabis Is Not Dead' Says Aurora CEO From Helm Of Largest Global Medical Marijuana Company
Last month Canadian marijuana giant, Aurora Cannabis Inc.
Prince Harry Says Cannabis Helped Him Cope With Mental Health Struggles & Ayahuasca Was A 'Release'
“Marijuana is different, that actually really did help me,” Prince Harry told physician and author Dr. Gabor Maté on Saturday in a widely viewed live-stream interview about the importance of personal healing.
Aurora And MedReleaf Australia Launch New Medical Cannabis Brand - CraftPlant
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) and MedReleaf Australia launched CraftPlant, a new medical cannabis brand for patients in the Australian market.
Aurora Cannabis Reports 2Q Results, Global Medical Cannabis Revenues Up
Aurora Cannabis Inc.
Aurora Cannabis' Health Plans, Hemp Pesticides In MA, Digital MJ Cards In NM, Virginia Delta 8, Oregon Pardons
Aurora Cannabis Aims For Health Plans In Canada
Aurora Cannabis Q1 Revenue Decreases 2% Sequentially, Following Wholesale Distribution Disruptions
Aurora Cannabis Inc. (NASDAQ: AC) (TSX: ACB), a Canadian leader in the cannabis industry serving both the medical and consumer markets,
Aurora Cannabis Reports 2022 Q4 Earnings: Revenue Flat Sequentially At C$50.2M, CEO Optimistic
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), a Canadian global company in the cannabis industry, serving both the medical and consumer markets; recently announced its financial and operational results for the fourth quarter a
Aurora Cannabis Acquires Controlling Interest In Greenhouse Tech Experts, Bevo Farms
Aurora Cannabis Inc.
Aurora Cannabis Announces More Layoffs, Here's Why
Aurora Cannabis Inc. (NASDAQ: ACB) continues to trim its workforce as it seeks to achieve profitability.
Jim Cramer Explains What Needs To Happen For Cannabis Stocks To Bounce Back
Cannabis investors are in the midst of earnings season, which is also a timely opportunity to take a glimpse at the stock performance of some big players within the space.
Aurora Gets EU-GMP Certification For Its Cannabis Production Facility In Germany
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has received EU-GMP certification for its state-of-the-art medical cannabis production facility in Germany.
Aurora Cannabis Reports Fiscal 2022 Q3 Results, Net Revenue $50.4M
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), a Canadian cannabis company, announced its financial and operational results late Thursday for the third quarter of fiscal 2022 ended March 31, 2022.
Aurora Cannabis Completes Acquisition Of Thrive Cannabis
Aurora Cannabis Inc.
Aurora Cannabis, GrowGen, The Parent Co. And Other Marijuana Operators Announces Earnings Release Dates
Several large cannabis operators announced their earnings release dates and conference calls.
EXCLUSIVE: Aurora Cannabis CEO 'Absolutely Confident' Company Will Be EBITDA-Positive By Year's End
Miguel Martin, CEO of Aurora Cannabis Inc (NASDAQ: ACB), discussed growing Aurora into the leader of the international medical cannabis market at the Benzinga Cannabis Capital Conference on Wednesday.